Editorial Board
(Source: HIV Medicine)
Source: HIV Medicine - September 4, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research
The extent of B ‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people
ConclusionsFLC‐κ, FLC‐λ and IgG levels were higher > 2 years before lymphoma diagnosis, suggesting that B‐cell dysfunction occurs many years prior to lymphoma development. However, the predictive value of each marker was low and they are unlikely candidates for risk assessment for targeted intervention. (Source: HIV Medicine)
Source: HIV Medicine - August 31, 2017 Category: Infectious Diseases Authors: L Shepherd, ÁH Borges, R Harvey, M Bower, A Grulich, M Silverberg, J Weber, M Ristola, J‐P Viard, JR Bogner, P Gargalianos‐Kakolyris, C Mussini, K Mansinho, I Yust, D Paduta, D Jilich, T Smiatacz, R Radoi, J Tomazic, P Plomgaard, R Frikke‐Schmidt, Tags: Original Research Source Type: research
Reply to Letter ‘Morning dosing for dolutegravir‐related insomnia and sleep disorders’ by Capetti et al.
(Source: HIV Medicine)
Source: HIV Medicine - August 29, 2017 Category: Infectious Diseases Authors: C Hoffmann, T Welz, M Sabranski, M Kolb, E Wolf, H ‐J Stellbrink, C Wyen Tags: Letter to the Editor Source Type: research
Reply to Letter ‘Morning dosing for dolutegravir‐related insomnia and sleep disorders’ by Capetti et al.
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 29, 2017 Category: Infectious Diseases Source Type: research
---
HIV Medicine, Ahead of Print. (Source: HIV Medicine)
Source: HIV Medicine - August 29, 2017 Category: Infectious Diseases Source Type: research
Argon plasma coagulation treatment of anal high ‐grade squamous intraepithelial lesions in men who have sex with men living with HIV: results of a 2‐year prospective pilot study
ConclusionsAPC can be used to treat anal HSILs in HIV‐seropositive MSM, and requires repeated treatment because of a high recurrence rate. As successful treatment of human papillomavirus (HPV) infection or eradication of the anal transitional zone remains impossible, HSIL treatment is challenging and requires long‐term follow‐up. (Source: HIV Medicine)
Source: HIV Medicine - August 23, 2017 Category: Infectious Diseases Authors: A Pokomandy, D Rouleau, R Lalonde, C Beauvais, C Castro, F Coutl ée, Tags: Original Research Source Type: research
No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France
Conclusions‘Population’ seems to be more relevant than EDI to define evidence‐based interventions to limit late diagnosis. (Source: HIV Medicine)
Source: HIV Medicine - August 18, 2017 Category: Infectious Diseases Authors: L Cuzin, Y Yazdanpanah, T Huleux, L Cotte, P Pugliese, C Allavena, J Reynes, I Poizot ‐Martin, F Bani‐Sadr, C Delpierre, Tags: Short Communication Source Type: research
---
HIV Medicine,Volume 19, Issue 3, Page 238-242, March 2018. (Source: HIV Medicine)
Source: HIV Medicine - August 18, 2017 Category: Infectious Diseases Source Type: research
HIV ‐infected patients' beliefs about their chronic co‐treatments in comparison with their combined antiretroviral therapy
ConclusionsPatients had higher Necessity and lower Concerns scores for their cART in comparison with their co‐treatments. A higher percentage of patients reported being adherent to cART compared with the co‐treatments that they reported they were most likely to miss. Further research using a bigger sample size and more objective measures of adherence is needed to explore the association between adherence and patients' perceptions. (Source: HIV Medicine)
Source: HIV Medicine - August 16, 2017 Category: Infectious Diseases Authors: S Kamal, O Bugnon, M Cavassini, MP Schneider Tags: Original Research Source Type: research
Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?
(Source: HIV Medicine)
Source: HIV Medicine - August 2, 2017 Category: Infectious Diseases Authors: R Rajasingham, DB Meya, DR Boulware Tags: Letter to the Editor Source Type: research
Morning dosing for dolutegravir ‐related insomnia and sleep disorders
(Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Authors: AF Capetti, S Di Giambenedetto, A Latini, G Sterrantino, I De Benedetto, MV Cossu, A Gori Tags: Letter to the Editor Source Type: research
Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Source Type: research
Morning dosing for dolutegravir ‐related insomnia and sleep disorders
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Source Type: research
---
HIV Medicine, Ahead of Print. (Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Source Type: research
